Piezowave² Shockwave Therapy
- the REAL direct and focused shock wave therapy
Dr. Rikke Johansen is excited to be one of the FIRST clinicians in the Palo Alto area to have the PiezoWave2T technology!
Myofascial Acoustic Compression Therapy (MyACT) utilizes acoustic waves to target tissue at varying depths, compressing and manipulating it to stimulate the body’s natural healing response. Through the use of PiezoWave2T technology, MyACT is used to treat acute and chronic pain in muscles, tendons, and joints.
The PiezoWave2T, developed by Richard Wolf, combines orthopedic applications of Extracorporeal Shock Wave Therapy (ESWT) with those of Trigger Point Shock Wave Therapy (TPST), which are highly efficient, non-surgical treatments for chronic musculoskeletal pain.
The PiezoWave2T offers a significant expansion of the range of applications for myofascial pain syndrome. The extracorporeal, focused shock wave allows for the precise diagnosis and therapy of active and latent trigger points, which are thickened, pain-sensitive points within a usually tense muscle.
How it Works
- the non-invasive alternative to surgery
The PiezoWave2T delivers mechanical energy in the form of sound waves to a target tissue, including tenocytes in tendons, fibroblasts in ligaments and skin, osteocytes in bone, chondrocytes in articular cartilage, and endothelial cells in blood vessels, which are all highly responsive to mechanical energy. The PiezoWave2T then localizes trigger points, delivering highly focused acoustic pulses that penetrate precisely to the desired depth. Penetration depths of between 0.5 mm and 3 cm are possible, depending on the therapy source. This facilitates cellular repair by increasing blood flow and reducing pain.
Extracorporeal shock waves have been used successfully in the treatment of chronic pain since the early ’90s in Europe. MyACT/PiezoWave2 has been used in Germany for the past 26 years. New to the United States only six years ago, the PiezoWave² is now an FDA-registered Class I modality.